Skip to main content
Gut logoLink to Gut
. 1993;34(2 Suppl):S127. doi: 10.1136/gut.34.2_suppl.s127

Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C.

C Panella 1, A Francavilla 1, D Conte 1, I Tatulli 1, F Rubini 1
PMCID: PMC1374036  PMID: 8314478

Abstract

In a study of 37 patients with hepatitis C (proved histologically) positive chronic hepatitis, a correlation was seen between clinical efficacy and histological improvement after treatment with interferon alfa-2b (3 million units (MU) three times a week for six months plus six months' follow up). Alanine aminotransferase activities became normal in 18 (48%) patients during treatment; at the end of follow up eight (45%) had a continued response to the treatment. Paired liver biopsy specimens showed marked improvements in Knodell index score and portal inflammation in these patients.

Full text

PDF

Page S127

S127


Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES